申请人:Vidal Juan Bernat
公开号:US20050070558A1
公开(公告)日:2005-03-31
6-phenylpyrrolopyrimidinedione derivatives of the formula (I), and pharmaceutically acceptable salts thereof, wherein R
1
, R
2
, R
3
, R
4
and R
5
are organic residues, L
1
is a spacer group and R
6
is C(O) NR
10
R
11
, —S(O)
2
NR
10
R
11
, ?
—ON═CR
12
R
13
, or a heterocyclyl, aryl?
or heteroaryl group, where R
10
, R
11
, R
12
and R
13
are organic residues, have therapeutic potential as A2 adenosine receptor inhibitors.
式(I)的6-苯基吡咯嘧啶二酮衍生物及其药学上可接受的盐,其中R1、R2、R3、R4和R5均为有机残基,L1为间隔基,R6为C(O)NR10R11、—S(O)2NR10R11、?—ON═CR12R13或杂环基、芳基或杂芳基,其中R10、R11、R12和R13为有机残基,具有作为A2腺苷受体抑制剂的治疗潜力。